Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Yasuhide Kitagawa, Hiroyuki Konaka, Chiung-Kuei Huang, Kouji Izumi, Atsushi Mizokami, Hiroshi Miyamoto, Yoshifumi Kadono, Aerken Maolake, Wen-Jye Lin, Mikio Namiki
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 140(8):1413-1419
Purpose Prostate-specific antigen (PSA) is a useful biomarker of prostate cancer (PCa). High-risk localized PCa is defined using T stage, Gleason score (GS), and PSA. However, PSA level defining high-risk PCa is at most 20 ng/mL. In PCa patients with
Autor:
Aslihan Guven Mert, Heves Sürmeli, Umut Kefeli, Dincer Aydin, Sinemis Yuksel, Ahmet Bilici, Ozlem Ercelep, Mehmet Aliustaoglu, A. Tan, Deniz Işik, Hatice Odabasi, Melike Ozcelik, Dilek Yavuzer
WOS: 000358156300004 PubMed ID: 25786367 A disintegrin and metalloproteinase (ADAM) 17 has been indicated to be an indispensable regulator of cellular events from proliferation to migration. Although prognostic importance of ADAM17 expression has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb698d89fdf55ec81465c2e5ed5ec2a
https://hdl.handle.net/20.500.12511/2221
https://hdl.handle.net/20.500.12511/2221
Patients with malignant fibrous histiocytoma of bone (MFH-B) and osteosarcoma reportedly have comparable survival rates, despite the lesser chemosensitivity of patients with MFH-B compared with those with osteosarcoma.We therefore asked (1) whether t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982cce61622276284a430e8357629aa0
https://europepmc.org/articles/PMC3018190/
https://europepmc.org/articles/PMC3018190/